These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

425 related articles for article (PubMed ID: 27095464)

  • 41. Characteristics of Opsoclonus-Myoclonus Syndrome in Patients of the Largest Pediatric Hospital in Latin America.
    Zeny MS; do Valle DA; Santos MLSF; Bara TS; Cordeiro ML
    Pediatr Neurol; 2024 May; 154():9-14. PubMed ID: 38430891
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Opsoclonus-myoclonus syndrome in children with neuroblastoma: description of 3 cases].
    Garus K; Balwierz W; Skowronek B; Szweda E; Kroczka S; Moryl-Bujakowska A
    Przegl Lek; 2010; 67(6):427-9. PubMed ID: 21344775
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Opsoclonus-myoclonus and anti-Hu positive limbic encephalitis in a patient with neuroblastoma.
    Morales La Madrid A; Rubin CM; Kohrman M; Pytel P; Cohn SL
    Pediatr Blood Cancer; 2012 Mar; 58(3):472-4. PubMed ID: 21480475
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Outcome and prognostic features in opsoclonus-myoclonus syndrome from infancy to adult life.
    Brunklaus A; Pohl K; Zuberi SM; de Sousa C
    Pediatrics; 2011 Aug; 128(2):e388-94. PubMed ID: 21788225
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Cancer and Autoimmunity: Paraneoplastic Neurological Disorders Associated With Neuroblastic Tumors.
    Mitchell WG; Blaes F
    Semin Pediatr Neurol; 2017 Aug; 24(3):180-188. PubMed ID: 29103425
    [TBL] [Abstract][Full Text] [Related]  

  • 46. An upfront immunomodulatory therapy protocol for pediatric opsoclonus-myoclonus syndrome.
    Wilbur C; Yea C; Licht C; Irwin MS; Yeh EA
    Pediatr Blood Cancer; 2019 Aug; 66(8):e27776. PubMed ID: 31033188
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Mycoplasma pneumoniae associated opsoclonus-myoclonus syndrome in three cases.
    Huber BM; Strozzi S; Steinlin M; Aebi C; Fluri S
    Eur J Pediatr; 2010 Apr; 169(4):441-5. PubMed ID: 19774394
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Opsoclonus-Myoclonus Syndrome: A New Era of Improved Prognosis?
    Galstyan A; Wilbur C; Selby K; Hukin J
    Pediatr Neurol; 2017 Jul; 72():65-69. PubMed ID: 28479124
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Late cognitive and adaptive outcomes of patients with neuroblastoma-associated opsoclonus-myoclonus-ataxia-syndrome: A report from the Children's Oncology Group.
    Kumar P; Willard VW; Embry L; Naranjo A; LaBarre B; Matthay KK; de Alarcon PA
    Pediatr Blood Cancer; 2024 Jul; 71(7):e31039. PubMed ID: 38689540
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Opsoclonus-Myoclonus Syndrome, Neuroblastoma, and Insulin-Dependent Diabetes Mellitus in a Child: A Unique Patient.
    Ghia T; Kanhangad M; Alessandri AJ; Price G; Gera P; Nagarajan L
    Pediatr Neurol; 2016 Feb; 55():68-70. PubMed ID: 26778146
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Paraneoplastic opsoclonus myoclonus syndrome associated with inflammatory myofibroblastic tumor in a pediatric patient.
    Gerstle K; Siddiqui A; Schulte JJ; Cohn SL
    Pediatr Blood Cancer; 2020 Aug; 67(8):e28218. PubMed ID: 32472953
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Postintervention acute opsoclonus myoclonus syndrome.
    Aquilina A; Dingli N; Aquilina J
    BMJ Case Rep; 2017 Apr; 2017():. PubMed ID: 28432174
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Role of BAFF in Opsoclonus-Myoclonus syndrome, a bridge between cancer and autoimmunity.
    Raffaghello L; Fuhlhuber V; Bianchi G; Conte M; Blaes F; Gambini C; Pistoia V
    J Leukoc Biol; 2013 Jul; 94(1):183-91. PubMed ID: 23610147
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Opsoclonus-myoclonus-ataxia syndrome in children.
    Bhatia P; Heim J; Cornejo P; Kane L; Santiago J; Kruer MC
    J Neurol; 2022 Feb; 269(2):750-757. PubMed ID: 33779841
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Clinical outcome in adult onset idiopathic or paraneoplastic opsoclonus-myoclonus.
    Bataller L; Graus F; Saiz A; Vilchez JJ;
    Brain; 2001 Feb; 124(Pt 2):437-43. PubMed ID: 11157570
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Rituximab treatment for relapsed opsoclonus-myoclonus syndrome.
    Toyoshima D; Morisada N; Takami Y; Kidokoro H; Nishiyama M; Nakagawa T; Ninchoji T; Nozu K; Takeshima Y; Takada S; Nishio H; Iijima K
    Brain Dev; 2016 Mar; 38(3):346-9. PubMed ID: 26375512
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Opsoclonus myoclonus syndrome secondary to abdominal neuroblastoma. Presentation of a pediatric clinical case].
    Urman G; Leivi M; Chamorro N; García B; Callea A; Grosman A
    Arch Argent Pediatr; 2019 Dec; 117(6):e651-e654. PubMed ID: 31758904
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Successful use of tacrolimus for treatment-refractory neuroblastoma-associated opsoclonus-myoclonus-ataxia syndrome: A case series.
    Delap S; Shah N; Kuns O; Franklin B; Skeens MA
    Pediatr Blood Cancer; 2024 Apr; 71(4):e30903. PubMed ID: 38321586
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Virus-induced opsoclonus-myoclonus syndrome during pregnancy].
    Alekseeva TM; Topuzova MP; Skripchenko NV; Simakov KV; Senkevich KA; Novozhilova MA; Agapova OY; Ternovykh IK; Chaykovskaya AD
    Zh Nevrol Psikhiatr Im S S Korsakova; 2020; 120(5):93-99. PubMed ID: 32621474
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Opsoclonus-myoclonus syndrome].
    Arroyo HA; Tringler N
    Medicina (B Aires); 2009; 69(1 Pt 1):64-70. PubMed ID: 19240003
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.